Cecilia Monge, MD, MPH, FACP photograph

Cecilia Monge, M.D., M.P.H., FACP

  • Center for Cancer Research
  • National Cancer Institute
Thoracic and GI Malignancies Branch


Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer and colorectal cancer. Her research interests also include Cancer Health Disparities.

Areas of Expertise

Gastrointestinal (GI) Malignancies
Hepatocellular Carcinoma
Biliary Tract Cancer
Colorectal Cancer
Cancer Health Disparities

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

Clinical Trials


Dr. Cecilia Monge is involved in clinical research focusing on novel first-in-human and early-phase clinical trials within the realm of gastrointestinal (GI) tumors and immunology. Her research interests also include Healthcare Disparities. She has served as chair and investigator of multiple early stage clinical  study protocols within the National Cancer Institute, National Institutes of Health. Dr. Monge is part of National Institutes of Health Institutional Review Board (IRB) and the National Cancer Institute Safety Review Committee.


Selected Publications

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner 5, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf1, Austin G Duffy and Tim F Greten
Journal for Immunotherapy of Cancer. 11: 2023.
Full-Text Article
[ Journal Article ]

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

Cecilia Monge, Erica C. Pehrsson , Changqing Xie, Austin G. Duffy, Donna Mabry,
Bradford J. Wood, David E. Kleiner, Seth M. Steinberg, William D. Figg, Bernadette Redd,
Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, and
Tim F. Greten
The Oncologist. XX: 1-13, 2022.
Full-Text Article
[ Journal Article ]

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Cecilia Monge, Changqing Xi, Seth M Steinberg, Tim F Greten
J Hepatocell Carcinoma. 31;8: 507-512, 2021.
Full-Text Article
[ Journal Article ]

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Cecilia Monge Bonilla, Nicole A McGrath, Jianyang Fu, Changqing Xie
Hepatoma Research. 6: 68, 2020.
Full-Text Article

Systemic treatment options for advanced biliary tract carcinoma

Changqing Xie, Nicole A McGrath, Cecilia Monge Bonilla, Jianyang Fu
J Gastroenterol. 55(10): 944-957, 2020.
Full-Text Article